Armata Pharmaceuticals Inc (ARMP)
AMEX
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ARMP market cap is 80.35M. The company's latest EPS is USD -0.5226 and P/E is -4.25.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 966k | 0 | 2.97M | 1.24M | 491k |
| Operating Income | -10.23M | -11.91M | -9.76M | -10.54M | -8.19M |
| Net Income | -25.02M | 8.99M | -5.48M | 2.6M | -6.53M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 823k | 4.47M | 5.51M | 4.53M | 5.17M |
| Operating Income | -21.59M | -23.82M | -36.95M | -40.89M | -42.44M |
| Net Income | -22.18M | -23.16M | -36.92M | -69.05M | -18.92M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 120.36M | 108.31M | 98.24M | 86.44M | 87.25M |
| Total Liabilities | 176.87M | 154.41M | 149.21M | 134.46M | 141.03M |
| Total Equity | -56.51M | -46.1M | -50.97M | -48.02M | -53.78M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 39.52M | 69.77M | 95.83M | 98.36M | 86.44M |
| Total Liabilities | 20.66M | 44.37M | 59.75M | 130.43M | 134.46M |
| Total Equity | 18.86M | 25.4M | 36.08M | -32.07M | -48.02M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.58M | -20.76M | -29.62M | -37.55M | -7.58M |
| Investing | -250k | -1.62M | -1.96M | -1.88M | -99k |
| Financing | 34.93M | 35.02M | 34.96M | 34.96M | 9.99M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.27M | -23.58M | -32.48M | -47.42M | -37.55M |
| Investing | -824k | -1.3M | -2.21M | -8.13M | -1.88M |
| Financing | 23.21M | 25.52M | 44.02M | 53.99M | 34.96M |
| Market Cap | 80.35M |
| Price to Earnings Ratio | -4.25 |
| Price to Sales Ratio | 15.52 |
| Price to Cash Ratio | 8.65 |
| Price to Book Ratio | -1.67 |
| Dividend Yield | - |
| Shares Outstanding | 36.19M |
| Average Volume (1 week) | 14.01k |
| Average Volume (1 Month) | 19.4k |
| 52 Week Change | -20.14% |
| 52 Week High | 3.4154 |
| 52 Week Low | 0.8981 |
| Spread (Intraday) | 0.47 (19.83%) |
| Company Name | Armata Pharmaceuticals Inc |
| Address |
711 capitol way s ste 204 olympia, washington 98501 1267 |
| Website | https://www.armatapharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
